These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 10435640

  • 1. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 1999 Jul 22; 18(29):4269-74. PubMed ID: 10435640
    [Abstract] [Full Text] [Related]

  • 2. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 2000 Aug 03; 19(33):3766-73. PubMed ID: 10949931
    [Abstract] [Full Text] [Related]

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 03; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 4. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL, Seth P, Jetten AM.
    Oncogene; 1997 May 01; 14(17):2111-22. PubMed ID: 9160891
    [Abstract] [Full Text] [Related]

  • 5. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG, Choi BH, Son SW, Yi SJ, Shin SY, Lee YH.
    Cell Signal; 2007 Jun 01; 19(6):1290-300. PubMed ID: 17307334
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS.
    Oncogene; 1999 Jan 28; 18(4):1023-32. PubMed ID: 10023678
    [Abstract] [Full Text] [Related]

  • 7. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.
    Chen Y, Robles AI, Martinez LA, Liu F, Gimenez-Conti IB, Conti CJ.
    Cell Growth Differ; 1996 Nov 28; 7(11):1571-8. PubMed ID: 8930407
    [Abstract] [Full Text] [Related]

  • 8. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.
    Park MJ, Kim EH, Park IC, Lee HC, Woo SH, Lee JY, Hong YJ, Rhee CH, Choi SH, Shim BS, Lee SH, Hong SI.
    Int J Oncol; 2002 Aug 28; 21(2):379-83. PubMed ID: 12118335
    [Abstract] [Full Text] [Related]

  • 9. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF.
    Haematologica; 1998 Sep 28; 83(9):771-7. PubMed ID: 9825572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T, Thiele CJ.
    Oncogene; 1998 Jun 25; 16(25):3337-43. PubMed ID: 9681834
    [Abstract] [Full Text] [Related]

  • 12. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 15. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B, Langan TA, Sclafani RA.
    Cell Growth Differ; 2000 Oct 17; 11(10):507-15. PubMed ID: 11063124
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Integrin signaling at the M/G1 transition induces expression of cyclin E.
    Hulleman E, Bijvelt JJ, Verkleij AJ, Verrips CT, Boonstra J.
    Exp Cell Res; 1999 Dec 15; 253(2):422-31. PubMed ID: 10585265
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.
    Kwon TK, Nordin AA.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):534-8. PubMed ID: 9299546
    [Abstract] [Full Text] [Related]

  • 20. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.